Oral anticoagulants and risk of dementia: A systematic review and meta-analysis of observational studies and randomized controlled trials
© 2018 Elsevier Ltd Atrial fibrillation (AF) is a documented risk factor for dementia. However, it is unclear whether oral anticoagulant (OAC) treatment can reduce the development of dementia or cognitive impairment. We conducted a systematic review and meta-analysis of the association between OAC u...
Saved in:
Main Authors: | Pajaree Mongkhon, Abdallah Y. Naser, Laura Fanning, Gary Tse, Wallis C.Y. Lau, Ian C.K. Wong, Chuenjid Kongkaew |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85056655865&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/62940 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study
by: Pajaree Mongkhon, et al.
Published: (2020) -
Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care
by: Pajaree Mongkhon, et al.
Published: (2020) -
Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: A population-based study in the UK
by: Hassan Alwafi, et al.
Published: (2020) -
Etiology of Dementia in Thai Patients
by: Pornpatr A. Dharmasaroja, et al.
Published: (2022) -
Facilitators and Barriers to Dementia Assessment and Diagnosis: Perspectives From Dementia Experts Within a Global Health Context
by: Alissa Bernstein Sideman, et al.
Published: (2022)